Results 111 to 120 of about 1,113 (188)
28-day survival rates of patients ingesting different volumes of 20% liquid paraquat (w/v).
Note: XBJ, Xuebijing injection.28-day survival rates of patients ingesting different volumes of 20% liquid paraquat (w/v).
Ping Gong (37151) +4 more
core +1 more source
Background: XueBiJing injection (XBJ) is renowned for its multi-target pharmacological effects, including immunomodulatory, antithrombotic, and antioxidant activities, offering potential therapeutic benefits for patients with severe infections such as ...
Shang-Fu Li +17 more
core +1 more source
Sepsis and septic shock threaten the survival of millions of patients in the intensive care unit. Secondary fungal infections significantly increased the risk of mortality in sepsis patients.
Yu, Qilin +10 more
core
BACKGROUND: This study aims to explore whether Xuebijing (XBJ) can improve intestinal microcirculation dysfunction in sepsis and its mechanism. METHODS: A rat model of sepsis was established by cecal ligation and puncture (CLP).
Tang, A-Ling +6 more
core +1 more source
To clarify and quantify the chemical profiling of XueBiJing injection (XBJ) rapidly, a feasible and accurate strategy was developed by applying ultra high performance liquid chromatography-Q Exactive hybrid quadrupole-orbitrap high resolution accurate ...
Jinfa Tang +7 more
core +1 more source
Increased vascular permeability leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is central to the pathogenesis of heatstroke.
Zhenglian Wang (693435) +15 more
core +1 more source
Effect of Xuebijing injection on coagulation function in emergency patients with severe sepsis
CHEN Min, SHAO Jianwei
doaj +1 more source
Correction: Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects. [PDF]
Honoré PM +5 more
europepmc +1 more source
Research Progress on Traditional Chinese Medicine Preparations in Respiratory Inflammatory Diseases. [PDF]
Liu X +6 more
europepmc +1 more source

